Balance Sheet
Daily Values
Growth Metrics
Income Statement
RevenueShares Outstanding (Weighted Average)
Others
Ratios

AC Immune (ACIU) Revenue (2017 - 2025)

AC Immune (ACIU) has disclosed Revenue for 4 consecutive years, with $50.0 million as the latest value for Q4 2025.

  • Quarterly Revenue changed N/A to $50.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $99.3 million through Dec 2025, up 101.52% year-over-year, with the annual reading at $4.5 million for FY2025, 85.66% down from the prior year.
  • Revenue for Q4 2025 was $50.0 million at AC Immune, up from $7.8 million in the prior quarter.
  • The five-year high for Revenue was $50.0 million in Q4 2025, with the low at $7.8 million in Q4 2023.
  • Average Revenue over 3 years is $33.1 million, with a median of $41.5 million recorded in 2022.
  • Peak annual rise in Revenue hit 81.27% in 2023, while the deepest fall reached 81.27% in 2023.
  • Over 3 years, Revenue stood at $41.5 million in 2022, then plummeted by 81.27% to $7.8 million in 2023, then surged by 543.38% to $50.0 million in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $50.0 million, $7.8 million, and $41.5 million for Q4 2025, Q4 2023, and Q4 2022 respectively.